Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

What to Expect From Biogen's Next Quarterly Earnings Report

Cambridge, Massachusetts-based Biogen Inc. (BIIB) discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. Valued at a market cap of $26.2 billion, the company is scheduled to announce its fiscal Q4 earnings for 2025 in the near future. 

Ahead of this event, analysts expect this healthcare company to report a profit of $1.72 per share, down 50% from $3.44 per share in the year-ago quarter. The company has topped Wall Street’s bottom-line estimates in three of the last four quarters, while missing on another occasion. In Q3, its EPS of $4.81 exceeded the consensus estimates by a notable margin of 23.7%. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.